Most Recent Articles
![2023 research report highlights breadth and impact of research at Providence](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzY2NDc5YTQzODZjMjUuanBnJnZlcnNpb249MDAwMCZzaWc9ZDJmYzU1MzQ0N2JlYTA4YjgwMzczOTA1ZDllMDMzZGE%25253D&size=1&version=1716229773&sig=18bed8556ca5b79ad7e3127794d3aaeb&default=hubs%2Ftilebg-blogs.jpg)
Providence researchers conducted over 2400 studies in 2023, according to the 2023 Providence Research Network Annual Report
![Angiosarcoma on the rise: new study reveals implications for cancer care and research](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzY2MWViNjlkNDY5NDYucG5nJnZlcnNpb249MDAwMCZzaWc9ZDNkNjAxMzk5YmFkY2U3ZGU2M2YxMTY2NDAyZTkxOWM%25253D&size=1&version=1713313658&sig=faf098071d15281247c6f4c50795f821&default=hubs%2Ftilebg-blogs.jpg)
The largest study of angiosarcoma published to date, co-authored at Providence, describes the incidence and presentation patterns of angiosarcoma, a rare but potentially deadly cancer.
![Improving access to cutting-edge research and clinical trials](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzY2MWViNDU2ZTJiZGYucG5nJnZlcnNpb249MDAwMCZzaWc9ZjQzNWZlOWVhMzgzMzZhNjk1ODg0YzYwMDZhZjQ3ZjY%25253D&size=1&version=1713390104&sig=9a52c3d1dbf0e69c354bbc6b35a182b2&default=hubs%2Ftilebg-blogs.jpg)
Two stories of how, together with our industry partners and patients, Providence is working to make the latest trials available to more people who could benefit from them.
![Providence researcher in the news: a promising treatment for kidney disease](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzY1OWVkMmQ4N2ZiNjEucG5nJnZlcnNpb249MDAwMCZzaWc9MWRhZWQ3YTAyNDRlZmNkODNkOTk1YTIxYjM5Y2QwMjU%25253D&size=1&version=1705017439&sig=f772584d7f3a18dd54d86dc80f90018a&default=hubs%2Ftilebg-blogs.jpg)
A study led by Providence researcher Katherine Tuttle, MD, FACP, of Spokane, Washington is in the news thanks to findings around a promising new treatment for kidney disease.
![A promising breakthrough in Leukemia treatments](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyMzIzNTlkN2NjZWYuanBlZyZ2ZXJzaW9uPTAwMDAmc2lnPWRjODQzZDZhMzllMGNkYzliMGI3MGJlMjJlZmFmNjE0&size=1&version=1692201593&sig=aa1d90be8a41ab690e24c34dd3dc0a7c&default=hubs%2Ftilebg-blogs.jpg)
A global study co-authored by Providence researchers shows significant promise for the treatment of Chronic lymphocytic leukemia/Small Lymphocytic Lymphoma
![2022 Providence research report highlights a year of impact & breakthroughs](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzY0NjY3OTgyMmJjOTcucG5nJnZlcnNpb249MDAwMCZzaWc9ZTdlNjU5N2E0NmM2ZjRmYzQ0ODQxMWY1NTQ0MGM2ZWE%25253D&size=1&version=1685656004&sig=4de8cbab71cf9d778e0db1caa08948fe&default=hubs%2Ftilebg-blogs.jpg)
The Providence Research Network 2022 Annual report highlights a year of impact and breakthroughs made possible by Providence's network of researchers, caregivers, scientists and research participants.
![Celebrating research & research participants this Clinical Trials Day](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzY0NjY2MDAzODhhOTgucG5nJnZlcnNpb249MDAwMCZzaWc9NzBiMWY0ZjhlNTVkNzgwODQyOTBhZjllMjlkNzNiMjA%25253D&size=1&version=1684448748&sig=577cb5b04bf4d42ab31fd056431da5f3&default=hubs%2Ftilebg-blogs.jpg)
Clinical Trials Day is celebrated annually on May 20th. This year, to celebrate the event, we’ve released our Providence Research Network annual research report.
![Providence researchers honored for studies of COVID-19’s impacts on colorectal cancer screenings & outcomes](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzY0MWM4MDg1ZTY2NTgucG5nJnZlcnNpb249MDAwMCZzaWc9YTdjOGNlZDdjMjYxM2RlMTY5OThjMzFhZTc0MWVjMjM%25253D&size=1&version=1679680951&sig=f9129e1a1e7b20abacb5e9dee5d58f09&default=hubs%2Ftilebg-blogs.jpg)
Providence researchers receive awards for two studies of COVID-19’s impacts on colorectal cancer screenings and outcomes
![Providence researchers study early detection test that can detect more than 50 cancer types](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYzZjk1YTZiMTZiYTUucG5nJnZlcnNpb249MDAwMCZzaWc9M2E5M2NkMjUyYmQyMWQwZDcwMDYzMzc4OTFkN2M4MzM%25253D&size=1&version=1677524857&sig=334271e729fac20585869b0843b2479c&default=hubs%2Ftilebg-blogs.jpg)
Providence researchers are studying a blood-based, multi-cancer early detection test able to detect more than 50 cancer types through a single blood draw.
![New research evaluates the safety of transplants from organ donors that tested positive for SARS-CoV-2](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYzOGZhMTY3YWY1OGMucG5nJnZlcnNpb249MDAwMCZzaWc9ZWRjMDkzNDQ4YmU0MGFiMjYzZWZjZTY1M2EwNzg3YzQ%25253D&size=1&version=1675702244&sig=1b9db1f3a5ac52f84948d4ff1325c283&default=hubs%2Ftilebg-blogs.jpg)
Evidence outlined in a new research publication co-authored by Dr. Jason Goldman of Providence Swedish could help respond to the shortage of donated organs during COVID-19.
![Partnering to expand colorectal cancer screening in communities of color](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYzNDlhY2VkOGY3YjAucG5nJnZlcnNpb249MDAwMCZzaWc9NTdjZmI2ZmI2NDdkYzJiNzkyZWE0OTgzNGJhMWNhZWI%25253D&size=1&version=1667428586&sig=5d68e0ca4b3d3a27dc975f1a54c96d0f&default=hubs%2Ftilebg-blogs.jpg)
Providence is partnering with Stand Up To Cancer on a multi-year effort called the CHAT project focused on increasing colorectal cancer screenings in communities of color.
![Community Health Workers can improve cancer care delivery, according to new research](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyOTAwMDQ1MTBmNzMuanBnJnZlcnNpb249MDAwMCZzaWc9MmMyZTlkMGFhYjFlMWNhNDUxODg2NDQ5M2E4NjQ2N2Y%25253D&size=1&version=1665681997&sig=858495e79eaa62d33dfa1233454aa37f&default=hubs%2Ftilebg-blogs.jpg)
Community Health Workers improve cancer care delivery for advanced cancer patients, according to new research
![Providence researchers help identify drug resistance and reversal mechanisms in breast cancer](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYxNjRhY2Y4NDkxZDIuanBnJnZlcnNpb249MDAwMCZzaWc9YTIxZDRjOWE3ZTJlY2M4ODFiMzE0ODkyMTNjYTJkYWQ%25253D&size=1&version=1665679078&sig=847633a0f5258d8b8e6e27dfafe63b24&default=hubs%2Ftilebg-blogs.jpg)
New studies co-authored by Providence Research Network Researchers help identify drug resistance and reversal mechanisms in breast cancer
![Addressing Inequities: The National African Americans with MS Registry](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyZTAyNjA0ZTE1ZTQucG5nJnZlcnNpb249MDAwMCZzaWc9ODBmNDkyOGY4Nzg0YjFkYmUyNjQ3NThkODliNTdlNWI%25253D&size=1&version=1665679078&sig=73258cdc09aafae6d61ef3fe491bde57&default=hubs%2Ftilebg-blogs.jpg)
The National African Americans with MS Registry is a patient-powered research registry focused on and led by African Americans.
![Providence researchers take on Polycystic Kidney Disease](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyYWNlNWU5MjQ0YmUucG5nJnZlcnNpb249MDAwMCZzaWc9OGNiZWE1MGFhNGZlNjM0MzA2NDFlMDUyMDRmMjdiY2I%25253D&size=1&version=1665679078&sig=74fc0abd0dda3330cdd56d19678c0174&default=hubs%2Ftilebg-blogs.jpg)
Clinical research at the Center for Polycystic Kidney Disease at Swedish offers hope to patients with PKD, one of the most common genetic diseases
![New report highlights research at providence](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyN2FjYWUxZTIxYjIuanBnJnZlcnNpb249MDAwMCZzaWc9OTE0NDY1OTA0MTBiMDkwMzMwNzczN2ViNGVlMTE2OGI%25253D&size=1&version=1665679078&sig=b38e54c851d0ea4705794c41ee7aa6ce&default=hubs%2Ftilebg-blogs.jpg)
A new report from the Providence Research Network highlights how Providence researchers are advancing the future of health and health care.
![Providence researchers assess changes in COVID-19 vaccine effectiveness over time](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYyNWY0MWFkN2RkMmMuanBlZyZ2ZXJzaW9uPTAwMDAmc2lnPTkzZGEwMmZhMDFhOWY3YmQyMzNiOTczYmVjNzI0Nzhi&size=1&version=1665679078&sig=ca31a6b619d520ad699dbaddb38b8bb0&default=hubs%2Ftilebg-blogs.jpg)
Learn how a team of Providence researchers analyzed how the protection from various COVID-19 vaccines decline over time
![Providence researchers examine COVID-19’s impacts on hospital mortality](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYxZmM2ZTlmY2Q1MDIuanBlZyZ2ZXJzaW9uPTAwMDAmc2lnPWIyNzM4YjExNWY2YmY4MWE2OTJmYzc3ZmZlOTMxM2E2&size=1&version=1665679078&sig=2cc97cdb087481dfae8c2d9c14b5bd75&default=hubs%2Ftilebg-blogs.jpg)
Providence is a leader in research to understand the impacts of COVID-19 on hospital mortality
![Q&A with Research Nurse Tara Foote](https://content.cdntwrk.com/mediaproxy?url=https%3A%2F%2Fcontent.cdntwrk.com%2Ffiles%2FaHViPTcxNTQ2JmNtZD1pdGVtZWRpdG9yaW1hZ2UmZmlsZW5hbWU9aXRlbWVkaXRvcmltYWdlXzYxYmY5NzI4M2NkM2MucG5nJnZlcnNpb249MDAwMCZzaWc9YWEwZGQ0Zjc5ZWMxMTA2ZDIzZjdjNDIyZWFmNTgxMjY%25253D&size=1&version=1665679078&sig=5c9250d601e8fd0674738bf82e68df3d&default=hubs%2Ftilebg-blogs.jpg)
Research nurse Tara Foote talks about her work at the Providence Cancer Center, what it's like to work with clinical trial patients- and what inspires her.